OPKO Health (OPK) is currently trading at $1.48, with a bullish outlook supported by its improving financial performance and strategic developments. The company reported a net income of $24.9 million in Q3 2024, a significant turnaround from a net loss in the prior year, and announced a share repurchase program, signaling confidence in its valuation. Analysts have set a price target of $3, indicating a potential upside of over 100%, driven by strong fundamentals and promising product advancements.